1,7-phenanthroline has been researched along with Cancer of Esophagus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Liu, C; Ma, J; Wang, L; Ye, J; Zhong, X | 1 |
| Han, Z; Mei, W; Sun, F; Yang, Q; Yu, Y; Zhen, N; Zheng, K | 1 |
| Davies, AM; Donnier-Marechal, M; Senge, MO; Sergeeva, NN; Vaz, GM | 1 |
3 other study(ies) available for 1,7-phenanthroline and Cancer of Esophagus
| Article | Year |
|---|---|
A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage.
Topics: Antigens, CD; Antineoplastic Agents; DNA Damage; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Iron Compounds; Phenanthrolines; Reactive Oxygen Species; Receptors, Transferrin | 2019 |
MiroRNA-127-3p targets XRCC3 to enhance the chemosensitivity of esophageal cancer cells to a novel phenanthroline-dione derivative.
Topics: Base Sequence; Cell Proliferation; DNA Breaks, Double-Stranded; DNA-Binding Proteins; Esophageal Neoplasms; Homologous Recombination; Humans; MicroRNAs; Phenanthrolines; Rad51 Recombinase | 2016 |
Simple but powerful: phenanthroline-based small molecules for cellular imaging and cancer screening.
Topics: Cell Line, Tumor; Endoplasmic Reticulum; Esophageal Neoplasms; Fluorescent Dyes; Humans; Microscopy, Confocal; Phenanthrolines | 2011 |